Alterity Therapeutics Limited (ASX:ATH)

Alterity Therapeutics Revenue

Alterity Therapeutics had revenue of 2.80M AUD in the half year ending December 31, 2025, with 47.49% growth. This brings the company's revenue in the last twelve months to 8.84M, up 137.32% year-over-year. In the fiscal year ending June 30, 2025, Alterity Therapeutics had annual revenue of 7.64M with 90.12% growth.

• Revenue (ttm): 8.84M
• Revenue Growth: +137.32%
• P/S Ratio: 14.75
• Revenue / Employee: 737.38K
• Employees: 9
• Market Cap: 97.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	7.64M	3.62M	90.12%
Jun 30, 2024	4.02M	102.95K	2.63%
Jun 30, 2023	3.92M	-1.21M	-23.56%
Jun 30, 2022	5.12M	638.30K	14.23%
Jun 30, 2021	4.49M	4.36M	3,554.58%
Jun 30, 2020	122.73K	-4.83M	-97.52%
Jun 30, 2019	4.95M	1.83M	58.40%
Jun 30, 2018	3.13M	103.10K	3.41%
Jun 30, 2017	3.02M	-1.87M	-38.27%
Jun 30, 2016	4.90M	-1.60M	-24.61%
Jun 30, 2015	6.49M	-1.71M	-20.89%
Jun 30, 2014	8.21M	3.57M	76.94%
Jun 30, 2013	4.64M	2.11M	83.56%
Jun 30, 2012	2.53M	2.36M	1,451.38%
Jun 30, 2011	162.92K	-52.09K	-24.23%
Jun 30, 2010	215.01K	-213.19K	-49.79%
Jun 30, 2009	428.19K	-62.92K	-12.81%
Jun 30, 2008	491.11K	-16.32K	-3.22%
Jun 30, 2007	507.44K	-542.85K	-51.69%
Jun 30, 2006	1.05M	-1.60M	-60.41%
Jun 30, 2005	2.65M	-	-